Electrophysiological Assessment of Murine Atria with High-Resolution Optical Mapping
February 22nd, 2018
11.9K views
This protocol describes the electrophysiological evaluation of murine atria utilizing an optical mapping system with a high temporal and spatial resolution, including dual recordings of the membrane voltage and Ca2+ transient under programmed stimulation through a specialized electrode catheter.
Overview
This protocol outlines the electrophysiological evaluation of murine atria using an optical mapping system. It emphasizes high temporal and spatial resolution for dual recordings of membrane voltage and Ca2+ transients under programmed stimulation.
Key Study Components
Area of Science
- Cardiac Electrophysiology
- Optical Mapping Techniques
- Atrial Arrhythmias
Background
- Understanding atrial arrhythmias is crucial for cardiac health.
- Genetic mutations can influence the development of these arrhythmias.
- Optical mapping allows for precise assessment of atrial electrical activity.
- Langendorff apparatus is essential for heart preparation and evaluation.
Purpose of Study
- To assess murine atrial electrophysiology with high resolution.
- To investigate mechanisms behind atrial arrhythmias.
- To utilize optical mapping for detailed conduction pattern analysis.
Methods Used
- Preparation of mouse heart using heparin and anesthesia.
- Langendorff perfusion setup with Tyrode's solution.
- Optical mapping for recording membrane voltage and calcium transients.
- Induction of atrial arrhythmias through programmed electrical stimulation.
Main Results
- Successful recording of membrane voltage and calcium dynamics.
- Identification of effective refractory periods and pacing thresholds.
- Observation of atrial tachyarrhythmias under specific pacing regimens.
- Detailed conduction patterns analyzed in murine atria.
Conclusions
- This method provides insights into atrial arrhythmia mechanisms.
- Optical mapping is a valuable tool for cardiac electrophysiological studies.
- Future studies can leverage this technique for further exploration of cardiac conditions.
Frequently Asked Questions
What is the main advantage of using optical mapping?
Optical mapping allows for high-resolution recordings of membrane voltage and calcium transients, providing detailed insights into cardiac electrophysiology.
How is the mouse heart prepared for the experiment?
The heart is prepared by anesthetizing the mouse, cannulating the aorta, and perfusing with Tyrode's solution.
What are the key measurements taken during the study?
Key measurements include membrane voltage, calcium transients, and electrocardiogram recordings during pacing.
What types of arrhythmias can be induced using this method?
The method can induce various atrial tachyarrhythmias through programmed electrical stimulation.
How long does the procedure take to complete?
Once mastered, the entire procedure can be completed in approximately three hours.
What precautions should be taken during the experiment?
It is important to minimize damage or stress to the atria, which could affect electrophysiological properties.
Executive Industry Relevance
High-resolution optical mapping enables precise electrophysiological phenotyping of murine atria, supporting mechanistic de-risking in atrial fibrillation target validation. This approach provides quantitative, reproducible data on conduction velocity, action potential duration, and arrhythmia inducibility, enhancing predictive confidence in early discovery. It bridges genetic findings to functional phenotypes, informing go/no-go decisions in cardiovascular drug discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by linking genotype to electrophysiological phenotype in disease-relevant murine models.
- Operational Value: Enables functional target validation through precise measurement of atrial electrophysiological parameters under programmed stimulation.
- Predictive Value: Supports portfolio triage by quantifying arrhythmia susceptibility and conduction abnormalities in genetic models.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream screening by establishing baseline electrophysiological profiles in healthy and diseased atria.
- Operational Value: Delivers standardized, high-throughput compatible readouts including activation maps and calcium transients with 20–100 µm/pixel resolution.
- Assay Readiness: Enables reliable compound evaluation through reproducible detection of drug-induced changes in conduction velocity and refractory periods.
Translational & Preclinical Research
- Translational Continuity: Maintains disease relevance by evaluating electrophysiological remodeling in pressure-overload murine models of atrial tachyarrhythmia.
- Preclinical Validation: Supports risk-adjusted advancement decisions by measuring inducibility of atrial tachyarrhythmias and re-entry circuit formation.
- Mechanistic De-risking: Clarifies pathway-level effects of genetic or pharmacological interventions on atrial electrophysiology.
Pipeline & Workflow Integration
The method integrates into the discovery continuum from target validation through lead identification to preclinical assessment, providing electrophysiological phenotyping at each stage.
- Discovery Biology: Supports hypothesis testing by mapping conduction patterns and identifying re-entry mechanisms during induced arrhythmias.
- Screening: Delivers assay-ready quantitative outputs such as action potential duration and calcium transient kinetics for compound screening.
- Analytics: Generates statistical outputs including conduction velocity maps and effective refractory period distributions for cross-condition comparison.
- Translational Research: Connects to preclinical continuity by evaluating arrhythmia susceptibility in models mimicking human atrial fibrillation substrates.
- Enterprise Reuse: Functions as a reusable electrophysiological profiling platform across multiple genetic and disease models.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in target validation by reducing mechanistic ambiguity in atrial electrophysiology.
- Operational Value: Ensures standardization and reproducibility through Langendorff-perfused heart preparation and dual-camera optical mapping.
- Strategic Value: Improves go/no-go decisions by providing quantitative arrhythmia inducibility data, reducing late-stage biological risk.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on electrophysiological de-risking in murine models.
Implementation Considerations
- Requires expertise in cardiac electrophysiology, optical mapping, and murine surgical techniques.
- Dependent on high-speed CMOS cameras, high-magnification optics, and voltage-sensitive/c calcium-indicator dyes.
- Necessitates cross-team standardization of perfusion protocols, staining procedures, and pacing regimens.
- Involves adaptation considerations for varying atrial sizes and disease-induced remodeling across models.
- Limited by the need to minimize mechanical stress during atrial flattening to preserve native electrophysiological properties.
Biopharma FAQs
Why does effective refractory period measurement matter for target validation?
Effective refractory period measurement determines the minimum interval between electrical stimuli that fails to depolarize the atrium, providing a quantitative indicator of electrical stability. This metric helps assess whether a genetic modification or compound alters atrial excitability, supporting mechanistic de-risking in target validation by identifying pro-arrhythmic or anti-arrhythmic effects early in discovery.
How does isolation of pacing stimuli as independent variables fit the discovery pipeline?
Isolating pacing stimuli such as constant, burst, or extra stimuli as independent variables enables controlled interrogation of atrial electrophysiological responses under defined conditions. This approach supports hypothesis-driven discovery by allowing researchers to test how specific interventions affect conduction, refractoriness, or arrhythmia susceptibility, aligning with stage-appropriate validation in the pipeline.
What do quantitative dependent variable measurements like conduction velocity enable?
Quantitative measurements of conduction velocity and action potential duration provide objective, numerical readouts of atrial electrophysiological function under baseline and stimulated conditions. These outputs enable comparison across genotypes, disease states, or treatment groups, facilitating data-driven decisions in lead optimization and preclinical candidate selection.
Why do replication requirements matter for cross-functional collaboration?
Replication requirements ensure that electrophysiological findings such as arrhythmia inducibility or conduction patterns are consistent across repeated experiments, which is essential for building confidence in target validation data. Consistent results across runs support reliable hand-off between discovery biology, assay development, and preclinical teams, reducing variability-induced delays in decision-making.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to analyze spatial and temporal data from optical mapping, including activation map generation, conduction velocity calculation, and action potential duration quantification across multiple beats and conditions. Statistical comparison of these parameters—such as mean conduction velocity or refractory period distributions—is necessary to detect significant differences between experimental groups and support robust scientific conclusions.
Chapters in this video
0:04
Title
0:48
Mouse Cannulation and Perfusion for Optical Mapping using Langendorff
3:37
Staining for Single Recording Membrane Voltage, Burst Pacing, and Extra-stimulus Pacing
6:37
Results: Conduction Patterns during Normal Sinus Rhythm and Atrial Tachyarrhythmia
7:49
Conclusion
